Titre:
  • Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.
Auteur:Criscitiello, Carmen; Abdel Azim, Hatem Hamdy; Agbor-Tarh, Dominique; Azambuja, Evandro; Piccart, P; Baselga, José; Eidtmann, Holger; Di Cosimo, Serena; Bradbury, Ian; Rubio, Isabel Teresa
Informations sur la publication:Annals of oncology, 24, 8, page (1980-1985)
Statut de publication:Publié, 2013-08
Sujet CREF:Cancérologie
Mots-clés:Breast cancer
Breast conservation
HER2
Neoadjuvant
Surgery
Trastuzumab
MeSH keywords:Adult
Antibodies, Monoclonal, Humanized -- therapeutic use
Antineoplastic Agents, Phytogenic -- therapeutic use
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- drug therapy -- surgery
Decision Making
Female
Humans
Mastectomy, Segmental
Middle Aged
Neoadjuvant Therapy
Paclitaxel -- therapeutic use
Quinazolines -- therapeutic use
Receptor, ErbB-2 -- metabolism
Receptors, Estrogen -- metabolism
Treatment Outcome
Young Adult
Note générale:Journal Article
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdt129
info:pii/mdt129
info:scp/84881227399
info:pmid/23567146